# ESTIMATION OF THE EFFECT OF MULTIPLE DOSE PF-06651600 ON THE PHARMACOKINETICS OF SINGLE DOSE MIDAZOLAM AND EFAVIRENZ

> **NCT03762928** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 12 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** PF-06651600
- **DRUG:** midazolam
- **DRUG:** efavirenz

## Key facts

- **NCT ID:** NCT03762928
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-07
- **Primary completion:** 2019-01-27
- **Final completion:** 2019-02-21
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03762928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03762928, "ESTIMATION OF THE EFFECT OF MULTIPLE DOSE PF-06651600 ON THE PHARMACOKINETICS OF SINGLE DOSE MIDAZOLAM AND EFAVIRENZ". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03762928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*